Business Description
Formosa Pharmaceuticals Inc
ISIN : TW0006838006
Total Employee Number:
10Description
Formosa Pharmaceuticals Inc is engaged in new drug development and transfers. Its Product pipeline includes TSY-110, TSY-120, TSY-310, APP13007 and APP13002.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 49.24 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.18 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.62 | |||||
Beneish M-Score | -0.74 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 73.8 | |||||
3-Year EBITDA Growth Rate | 59.5 | |||||
3-Year EPS without NRI Growth Rate | 47.8 | |||||
3-Year FCF Growth Rate | 34.2 | |||||
3-Year Book Growth Rate | 34.2 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 61.66 | |||||
9-Day RSI | 51.87 | |||||
14-Day RSI | 47.85 | |||||
3-1 Month Momentum % | 0.81 | |||||
6-1 Month Momentum % | -11.37 | |||||
12-1 Month Momentum % | -23.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 14.63 | |||||
Quick Ratio | 14.59 | |||||
Cash Ratio | 12.82 | |||||
Days Inventory | 71.93 | |||||
Days Sales Outstanding | 69.18 | |||||
Days Payable | 32.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.9 | |||||
Shareholder Yield % | -0.01 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 57.35 | |||||
Operating Margin % | -323.92 | |||||
Net Margin % | -361.42 | |||||
EBITDA Margin % | -255.87 | |||||
FCF Margin % | -621.16 | |||||
OCF Margin % | -547.01 | |||||
ROE % | -12.93 | |||||
ROA % | -9.24 | |||||
ROIC % | -28.98 | |||||
3-Year ROIIC % | 132.84 | |||||
ROC (Joel Greenblatt) % | -326.46 | |||||
ROCE % | -9.78 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 66.66 | |||||
PB Ratio | 2.55 | |||||
Price-to-Tangible-Book | 3.77 | |||||
EV-to-EBIT | -12.35 | |||||
EV-to-EBITDA | -17.18 | |||||
EV-to-Revenue | 43.94 | |||||
EV-to-FCF | -7.08 | |||||
Price-to-GF-Value | 0.35 | |||||
| Price-to-Net-Current-Asset-Value | 4.2 | |||||
| Price-to-Net-Cash | 5.28 | |||||
Earnings Yield (Greenblatt) % | -8.09 | |||||
FCF Yield % | -9.33 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Formosa Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 52.585 | ||
| EPS (TTM) (NT$) | -1.251 | ||
| Beta | -0.6901 | ||
| 3-Year Sharpe Ratio | -0.7 | ||
| 3-Year Sortino Ratio | -0.95 | ||
| Volatility % | 16.65 | ||
| 14-Day RSI | 47.85 | ||
| 14-Day ATR (NT$) | 0.537232 | ||
| 20-Day SMA (NT$) | 23.125 | ||
| 12-1 Month Momentum % | -23.82 | ||
| 52-Week Range (NT$) | 22.35 - 34 | ||
| Shares Outstanding (Mil) | 150.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Formosa Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Formosa Pharmaceuticals Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Formosa Pharmaceuticals Inc Frequently Asked Questions
What is Formosa Pharmaceuticals Inc(TPE:6838)'s stock price today?
The current price of TPE:6838 is NT$23.20. The 52 week high of TPE:6838 is NT$34.00 and 52 week low is NT$22.35.
When is next earnings date of Formosa Pharmaceuticals Inc(TPE:6838)?
The next earnings date of Formosa Pharmaceuticals Inc(TPE:6838) is .
Does Formosa Pharmaceuticals Inc(TPE:6838) pay dividends? If so, how much?
Formosa Pharmaceuticals Inc(TPE:6838) does not pay dividend.
Press Release
Articles on Formosa Pharmaceuticals Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers